about
Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysisA phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumorsPaclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer.Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyAnti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitroOxaliplatin. A platinum compound for colorectal cancer?Oxaliplatin: a review of evolving concepts.Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumorsUnique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.A tetrazolato-bridged dinuclear platinum(II) complex exhibits markedly high in vivo antitumor activity against pancreatic cancer.A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells.Investigation of interaction between human hemoglobin A0 and platinum anticancer drugs by capillary isoelectric focusing with whole column imaging detection.A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines.
P2860
Q26824087-B62F5104-518A-47DD-A945-C8E5FDD85887Q33405390-E9D2AF8E-ED98-4739-9061-E5804685B2ABQ33653575-C75FAF22-5044-436B-B68B-B06AC3DF4706Q33729150-3CA32984-FE92-49CF-BC7D-869D25D73B81Q33964850-25240163-CB36-492C-ADDA-095455A8DBE5Q34128227-94ED117C-9035-4D71-A13F-C6988CE87F4CQ34566202-C722DDD9-EDEA-4041-A570-305879A3EB72Q34569008-C8C9909A-F5E6-45F2-9591-421F4D563B01Q36610915-BE125598-9A41-4305-8EEF-81CB97A21CA8Q37187978-367045D4-1089-423F-A2B1-41C2C1866382Q37868960-38CB5D21-D8AA-491F-BABB-76E9D6721BA0Q39162262-03DDB4EB-D498-42B7-8DA3-0091D630A6EFQ39557153-9D4B28A8-5774-4192-A134-E6D8C76C773AQ39982489-9A1BD336-32E0-42D3-9002-89CC59524A8FQ40397420-78DB7250-73D4-41BE-B1F6-E92E562C63D4Q40627120-94D4A5ED-E85A-40C6-8BED-40A7134E83ADQ46228083-CAB62199-3CE6-46FB-96D8-EF3036C94940Q46485083-C0A49F6E-4524-43E3-AFCF-E6E867651F16Q46618992-792AA164-E58D-4EB4-BAC9-3403CEDDE8B3Q46932193-F26FE325-3402-4144-A483-29AA121E8EB9Q53251531-DD78061C-95E3-4668-A40C-659276E69E41
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Ongoing and unsaid on oxaliplatin: the hope
@ast
Ongoing and unsaid on oxaliplatin: the hope
@en
type
label
Ongoing and unsaid on oxaliplatin: the hope
@ast
Ongoing and unsaid on oxaliplatin: the hope
@en
prefLabel
Ongoing and unsaid on oxaliplatin: the hope
@ast
Ongoing and unsaid on oxaliplatin: the hope
@en
P2860
P921
P356
P1476
Ongoing and unsaid on oxaliplatin: the hope
@en
P2093
Cvitkovic E
P2860
P2888
P356
10.1038/BJC.1998.429
P407
P478
77 Suppl 4
P577
1998-06-01T00:00:00Z